Published: Sat, February 10, 2018
Business | By Max Garcia

Analysts See $-0.46 EPS for Seattle Genetics, Inc. (SGEN)


(NASDAQ:MYGN) shares with value of $201,000 were sold by DREISMANN HEINRICH.

Zynga Inc. (ZNGA) remained successful in beating the consensus-estimated $0.02 as it actually earned $0.03 per share in its last reported financial results. The company has a market capitalization of $2,340.00, a PE ratio of 22.86, a PEG ratio of 2.17 and a beta of 0.32. The stock decreased 2.58% or $1.4 during the last trading session, reaching $52.84. Susquehanna Int Gp Llp accumulated 2.26 million shares or 0.05% of the stock. It has outperformed by 10.05% the S&P500. Myriad Genetics had a return on equity of 9.54% and a net margin of 13.28%. Cornercap Investment Counsel Inc sold 44,165 shares as the company's stock declined 20.24% while stock markets rallied. The institutional investor held 41,263 shares of the health care company at the end of 2017Q3, valued at $2.25 million, up from 35,093 at the end of the previous reported quarter.

Myriad Genetics, Inc. has a 12 month low of $15.71 and a 12 month high of $41.57. The stock is now showing downward return of -5.88% throughout last week and witnessed decreasing return of -4.07% in one month period. At one point in the past year, the shares traded as low as $45.31 but has recovered 19.71% since then. It has outperformed by 58.98% the S&P500. Therefore 20% are positive. Facebook had 236 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Gartner, Inc. (NASDAQ:WDAY) has "Overweight" rating given on Friday, February 17 by Piper Jaffray. Seattle Genetics had 58 analyst reports since July 31, 2015 according to SRatingsIntel. BMO Capital Markets maintained Gartner, Inc. (NASDAQ:FB) rating on Tuesday, August 18. Piper Jaffray initiated Oracle Corporation (NYSE:ORCL) rating on Wednesday, October 4. Morgan Stanley has "Equal-Weight" rating and $1 target. The stock has "Buy" rating by UBS on Thursday, July 30. RBC Capital Markets maintained Gartner, Inc. As per Thursday, February 1, the company rating was maintained by Telsey Advisory. Leerink Swann maintained the shares of SGEN in report on Friday, August 14 with "Outperform" rating. Shares for $42.50M were sold by Zuckerberg Mark on Friday, August 25. FUCHS ANNE SUTHERLAND sold 5,000 shares worth $585,105. The insider King Gary A. sold 34,445 shares worth $1.37M. The insider GILBERT WALTER PHD sold 7,500 shares worth $248,925.

Investors sentiment increased to 1.01 in 2017 Q3. Its down 0.16, from 1.02 in 2017Q2. It is positive, as 57 investors sold TSCO shares while 152 reduced holdings. State Of Tennessee Treasury Department accumulated 0.11% or 224,909 shares. Cornercap Investment Counsel Inc who had been investing in Tractor Supply Co Com for a number of months, seems to be less bullish one the $8.45B market cap company. (NASDAQ:FB). The Oklahoma-based Inc Ok has invested 0.02% in Facebook, Inc. Fukoku Mutual Life Insurance Com has invested 0.02% in The AES Corporation (NYSE:AES).

Seattle Genetics Incorporated (NASDAQ:SGEN) had an increase of 1.42% in short interest. Meritage invested in 56,738 shares. Campbell And Adviser Ltd Limited Liability Company invested in 0.24% or 5,356 shares. 81,616 are owned by Sg Americas Secs Ltd Liability Corp. Teachers Retirement Of The State Of Kentucky has 78,100 shares. Amp Cap holds 0.05% in Assurant, Inc. (NASDAQ:SGEN) for 84,337 shares. Profund Advsrs Lc reported 40,084 shares stake. Halsey Ct has 3.25% invested in Facebook, Inc. Contour Asset Management Llc, a New York-based fund reported 995,376 shares. Its down 0.50, from 1.67 in 2017Q2. It worsened, as 51 investors sold SGEN shares while 74 reduced holdings. 71 funds opened positions while 145 raised stakes. 140.23 million shares or 2.00% more from 137.48 million shares in 2017Q2 were reported. Arizona State Retirement reported 0.02% stake. Quantbot Technologies LP raised its position in Seattle Genetics by 116.5% in the 3rd quarter. Finally, Northern Trust Corp lifted its position in Seattle Genetics by 0.4% in the 2nd quarter. (NASDAQ:SGEN) established that the company was able to keep return on investment at -17.06 in the trailing twelve month while Reuters data showed that industry's average stands at 2.84 and sector's optimum level is 14.11. Sivik Global Healthcare Ltd holds 0.56% in Seattle Genetics, Inc. Qs Ltd Liability holds 4,283 shares or 0% of its portfolio. Van Eck Assoc Corporation reported 293,466 shares or 0.09% of all its holdings. The SI to Seattle Genetics Incorporated's float is 13.52%. Pnc Fin Svcs Group holds 273,786 shares. Pggm accumulated 280,928 shares or 0.02% of the stock. Pinebridge Investments Limited Partnership holds 0.08% or 93,568 shares in its portfolio. (NYSE:IT). Greenleaf reported 122 shares. Macquarie Group has invested 0.01% in Seattle Genetics, Inc. The Ohio-based Huntington Bank & Trust has invested 0% in Seattle Genetics, Inc. Therefore 29% are positive. Bank of America upgraded Seattle Genetics, Inc. The firm has "Underperform" rating by Bank of America given on Friday, July 29. Prudential Financial Inc. now owns 6,291 shares of the biotechnology company's stock valued at $325,000 after acquiring an additional 400 shares in the last quarter. The rating was initiated by Wolfe Research on Wednesday, November 4 with "Peer Perform". The stock has "Neutral" rating by Goldman Sachs on Thursday, September 15. The firm earned "Hold" rating on Wednesday, September 28 by Jefferies. (NASDAQ:SGEN) earned "Hold" rating by J.P. Morgan on Thursday, June 8. The stock of Myriad Genetics, Inc. (NYSE:IT) on Friday, January 19 with "Buy" rating. Jefferies has "Buy" rating and $5300 target. The rating was upgraded by Wells Fargo to "Market Perform" on Tuesday, August 25.

Since August 24, 2017, it had 1 buying transaction, and 16 sales for $189.84 million activity. DOBMEIER ERIC also sold $255,900 worth of Seattle Genetics, Inc. 10,000 shares were sold by DRACHMAN JONATHAN G, worth $475,414. The rating was maintained by RBC Capital Markets with "Hold" on Sunday, September 10. The insider Cline Darren S sold 1,788 shares worth $85,635. BAKER BROS. ADVISORS LP bought $200.00 million worth of Seattle Genetics, Inc. Farr Miller And Washington Ltd Llc Dc holds 0.03% or 5,115 shares in its portfolio.

Like this: